慢性炎症与结直肠癌微环境
Chronic Inflammation and Colorectal Cancer Microenvironment

DOI: 10.12677/ACM.2015.54032, PP. 199-206

Keywords: 慢性炎症，结直肠癌，炎症细胞因子，IL-6，TNF-α，TGF-β
Chronic Inflammation, Colorectal Cancer, Inflammatory Cytokines, IL-6, TNF-α, TGF-β

Full-Text   Cite this paper   Add to My Lib

Abstract:

炎症是由病原体的侵袭，物理性或者化学性的损伤引起的十分常见而又重要的基本病理过程，通常可依病程经过分为两大类：急性炎症(acute inflammation)和慢性炎症(chronic inflammation)。急性炎症主要的功能是消除感染损伤的组织，维持体内的生理平衡，慢性炎症却可以引起细胞的恶性转化，进而引起癌症的发生。已有研究结果表明许多的炎症细胞因子在癌症的起始和发展过程中起着很重要的作用，如IL-6，TNF-α和TGF-β等。在本综述中，我们认为这些炎症因子在诱导癌变的过程中发挥了很重要的作用，同时我们分析了这些炎症细胞因子在结直肠炎相关结直肠癌发生过程中的作用。
Inflammation is a very common and important basic pathological process, mainly by the pathogen, physical or chemical damage caused. The course of the disease is divided into two broad categories: acute inflammation and chronic inflammation. The main function of acute inflammation is to eliminate infection of the organization, to maintain the physiological balance in the body. Chronic inflammation can cause cell malignant transformation, resulting in the occurrence of cancer. The existing research results show that many inflammatory cytokines play an important role in the process of development and cancer initiation, such as IL-6, TNF-alpha and TGF-beta. In this review, we argue that these inflammatory factors have played a very important role in the process of in-duced cancer. At the same time, we analyzed its effect of the process of the inflammatory cytokines in proctitis related colorectal cancer.

References

[1]	David, H. (1988) Rudolf Virchow and Modern Aspects of Tumor Pathology. Pathology—Research and Practice, 183, 356-364. http://dx.doi.org/10.1016/S0344-0338(88)80138-9
[2]	Balkwill, F. and Mantovani, A. (2001) Inflam-mation and Cancer: Back to Virchow? Lancet, 357, 539-545. http://dx.doi.org/10.1016/S0140-6736(00)04046-0
[3]	Hussain, S.P. and Harris, C.C. (2007) Inflammation and Cancer: An Ancient Link with Novel Potentials. International Journal of Cancer, 121, 2373-2380. http://dx.doi.org/10.1002/ijc.23173
[4]	Fernandes, J.V., Cobucci, R.N., Jatoba, C.A., et al. (2015) The Role of the Mediators of Inflammation in Cancer Development. Pathology and Oncology Research, 21, 527-534. http://dx.doi.org/10.1007/s12253-015-9913-z
[5]	Rubin, D.C., Shaker, A. and Levin, M.S. (2012) Chronic Intes-tinal Inflammation: Inflammatory Bowel Disease and Colitis- Associated Colon Cancer. Frontiers in Immunology, 3, 107. http://dx.doi.org/10.3389/fimmu.2012.00107
[6]	Yang, G.Y., Taboada, S. and Liao, J. (2009) Inflammatory Bowel Disease: A Model of Chronic Inflammation-Induced Cancer. Methods in Molecular Biology, 511, 193-233. http://dx.doi.org/10.1007/978-1-59745-447-6_9
[7]	Wilson, A.J., Barham, W., Saskowski, J., et al. (2013) Tracking NF-κB Activity in Tumor Cells during Ovarian Cancer Progression in a Syngeneic Mouse Model. Journal of Ovarian Research, 6, 63. http://dx.doi.org/10.1186/1757-2215-6-63
[8]	Yu, H., Pardoll, D. and Jove, R. (2009) STATs in Cancer In-flammation and Immunity: A Leading Role for STAT3. Nature Reviews Cancer, 9, 798-809. http://dx.doi.org/10.1038/nrc2734
[9]	O’Shea, J.J., Holland, S.M. and Staudt, L.M. (2013) JAKs and STATs in Immunity, Immunodeficiency, and Cancer. The New England Journal of Medicine, 368, 161-170. http://dx.doi.org/10.1056/NEJMra1202117
[10]	Yao, P.L., Morales, J.L., Zhu, B., et al. (2014) Activation of Pe-roxisome Proliferator-Activated Receptor-β/δ (PPAR- β/δ) Inhibits Human Breast Cancer Cell Line Tumorigenicity. Molecular Cancer Therapeutics, 2014, 13, 1008-1017. http://dx.doi.org/10.1158/1535-7163.MCT-13-0836
[11]	Takeda, Y., Yashima, K., Hayashi, A., Sasaki, S., Ka-waguchi, K., Harada, K., Murawaki, Y. and Ito, H. (2012) Expression of AID, P53, and Mlh1 Proteins in Endoscopi-cally Resected Differentiated-Type Early Gastric Cancer. World Journal of Gastrointestinal Oncology, 4, 131-137. http://dx.doi.org/10.4251/wjgo.v4.i6.131
[12]	Lu, H., Ouyang, W. and Huang, C. (2006) Inflammation, a Key Event in Cancer Development. Molecular Cancer Research, 4, 221-233. http://dx.doi.org/10.1158/1541-7786.MCR-05-0261
[13]	Ricciardi, M., Zanotto, M., Malpeli, G., Bassi, G., Per-bellini, O., Chilosi, M., Bifari, F. and Krampera, M. (2015) Epithelial-to-Mesenchymal Transition (EMT) Induced by Inflammatory Priming Elicits Mesenchymal Stromal Cell-Like Immune-Modulatory Properties in Cancer Cells. British Journal of Cancer, 112, 1067-1075. http://dx.doi.org/10.1038/bjc.2015.29
[14]	刘斌, 阳惠湘. 溃疡性结肠炎相关性结直肠癌的危险因素及预防[J]. 国际病理科学与临床杂志, 2012, 32(3): 244- 252.
[15]	Cui, Y. and Li, S. (2014) Hypoxia, Epithelia-Mesenchymal Transition and Cancer. Chinese Journal of Pathology, 43, 203-206.
[16]	Dezso, Z., Oestreicher, J., Weaver, A., Santiago, S., Agoulnik, S., Chow, J., Oda, Y. and Funahashi, Y. (2014) Gene Expression Profiling Reveals Epithelial Mesenchymal Transition (EMT) Genes Can Selectively Differentiate Eribulin Sensitive Breast Cancer Cells. PLoS ONE, 9, e106131. http://dx.doi.org/10.1371/journal.pone.0106131
[17]	Hagerling, C., Casbon, A.J. and Werb, Z. (2015) Balancing the Innate Immune System in Tumor Development. Trends in Cell Biology, 25, 214-220. http://dx.doi.org/10.1016/j.tcb.2014.11.001
[18]	张晶, 钟武, 李松. TNF-α抑制剂的研究进展[J]. 中国药物化学杂志, 2010(4): 310-318.
[19]	杨季云, 张思仲, 郭红. TNF-α通过激活NF-κB信号通路加快肝细胞周期进程[J]. 生物化学与生物物理进展, 2007, 34(6): 604-610.
[20]	向春艳, 何小燕, 李逐波, 刘衍季, 赖翔宇. TNF-α在癌症中的作用研究进展[J]. 生命科学, 2012, 21(3): 250-254.
[21]	王文珊, 傅冷西, 叶君健. TNF-α信号传导通路的研究进展[J]. 福建医科大学学报, 2005, 39(S1): 27-31.
[22]	Valentine, F.T. (1974) Soluble Factors Produced by Lymphocytes. Annals of the New York Academy of Sciences, 221, 317-323. http://dx.doi.org/10.1111/j.1749-6632.1974.tb28232.x
[23]	Wallach, D. (2013) The TNF Cytokine Family: One Track in a Road Paved by Many. Cytokine, 63, 225-229. http://dx.doi.org/10.1016/j.cyto.2013.05.027
[24]	Honchel, R., McDonnell, S., Schaid, D.J. and Thibodeau, S.N. (1996) Tumor Necrosis Factor-Alpha Allelic Frequency and Chromosome 6 Allelic Imbalance in Patients with Colorectal Cancer. Cancer Research, 56, 145-149.
[25]	Whittle, B.J., Varga, C., Berko, A., Horvath, K., Posa, A., Riley, J.P., Lundeen, K.A., Fourie, A.M. and Dunford, P.J. (2008) Attenuation of Inflammation and Cytokine Production in Rat Colitis by a Novel Selective Inhibitor of Leukotriene A4 Hydrolase. British Journal of Pharmacology, 153, 983-991. http://dx.doi.org/10.1038/sj.bjp.0707645
[26]	Chakrabarti, A., Talukdar, D., Pal, A. and Ray, M. (2014) Immunomodulation of Macrophages by Methylglyoxal Conjugated with Chitosan Nanoparticles against Sarcoma-180 Tumor in Mice. Cellular Immunology, 287, 27-35. http://dx.doi.org/10.1016/j.cellimm.2013.11.006
[27]	Chaftari, A.M., Hachem, R., Reitzel, R., Jordan, M., Jiang, Y., Yousif, A., et al. (2015) Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection. PLoS ONE, 10, e130999. http://dx.doi.org/10.1371/journal.pone.0130999
[28]	Do, D.V., Ueda, J., Messerschmidt, D.M., Lorthongpanich, C., Zhou, Y., Feng, B., et al. (2013) A Genetic and Developmental Pathway from STAT3 to the OCT4-NANOG Circuit Is Essential for Maintenance of ICM Lineages in Vivo. Genes & Development, 27, 1378-1390. http://dx.doi.org/10.1101/gad.221176.113
[29]	Qu, Z.X., Sun, F., Zhou, J.J., Li, L.W., Shapiro, S.D. and Xiao, G.T. (2015) Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer. Cancer Research, 75, 3209-3215. http://dx.doi.org/10.1158/0008-5472.CAN-14-3042
[30]	牛秀珑, 王越, 梁国庆. 转化生长因子β的研究进展[J]. 医学综述, 2004, 10(4): 209-210.
[31]	吴学玲, 王先酉. 转化生长因子β的研究进展[J]. 南华大学学报(医学版), 2004, 30(2): 179-180.
[32]	Glansbeek, H.L., van der Kraan, P.M., Lafeber, F.P., Vitters, E.L. and van den Berg, W.B. (1997) Species-Specific Expression of Type II TGF-Beta Receptor Isoforms by Articular Chondrocytes: Effect of Proteoglycan Depletion and Aging. Cytokine, 9, 347-351. http://dx.doi.org/10.1006/cyto.1996.0175
[33]	Kashiwagi, I., Morita, R., Schichita, T., Komai, K., Saeki, K., Matsumoto, M., et al. (2015) Smad2 and Smad3 Inversely Regulate TGF-Beta Autoinduction in Clostridium Butyricum-Activated Dendritic Cells. Immunity, 43, 65-79.
[34]	Goswami, M.T., Reka, A.K., Kurapati, H., Kaza, V., Chen, J., Standiford, T.J. and Keshamouni, V.G. (2015) Regulation of Complement-Dependent Cytotoxicity by TGF-Beta-Induced Epithelial-Mesenchymal Transition. Oncogene. http://dx.doi.org/10.1038/onc.2015.258
[35]	Mendes, F., Antunes, C., Abrantes, A.M., Gon？alves, A.C., No-bre-Gois, I., Sarmento, A.B., Botelho, M.F. and Rosa, M.S. (2015) Lung Cancer: The Immune System and Radiation. British Journal of Biomedical Science, 72, 78-84.
[36]	Guasch, G., Schober, M., Pasolli, H.A., Conn, E.B., Polak, L. and Fuchs, E. (2007) Loss of TGFβ Signaling Destabilizes Homeostasis and Promotes Squamous Cell Carcinomas in Stratified Epithelia. Cancer Cell, 12, 313-327. http://dx.doi.org/10.1016/j.ccr.2007.08.020
[37]	Fearnhead, N.S., Wilding, J.L. and Bodmer, W.F. (2002) Genetics of Colorectal Cancer: Hereditary Aspects and Overview of Colorectal Tumorigenesis. British Medical Bulletin, 64, 27-43. http://dx.doi.org/10.1093/bmb/64.1.27
[38]	Gonzalez-Pons, M. and Cruz-Correa, M. (2015) Colorectal Cancer Biomarkers: Where Are We Now? BioMed Research International, 2015, Article ID: 149014. http://dx.doi.org/10.1155/2015/149014
[39]	Fearon, E.R. and Vogelstein, B. (1990) A Genetic Model for Colo-rectal Tumorigenesis. Cell, 61, 759-767. http://dx.doi.org/10.1016/0092-8674(90)90186-I
[40]	秦淼, 房静远. 炎症小体与肿瘤发生的研究进展[J]. 肿瘤, 2013, 33(6): 556-560.
[41]	Fouad, T.M., Kogawa, T., Reuben, J.M. and Ueno, N.T. (2014) The Role of Inflam-mation in Inflammatory Breast Cancer. Advances in Experimental Medicine and Biology, 816, 53-73. http://dx.doi.org/10.1007/978-3-0348-0837-8_3
[42]	Nittka, S., Gunther, J., Ebisch, C., Erbersdobler, A. and Neumaier, M. (2004) The Human Tumor Suppressor CEACAM1 Modulates Apoptosis and Is Implicated in Early Co-lorectal Tumorigenesis. Oncogene, 23, 9306-9313. http://dx.doi.org/10.1038/sj.onc.1208259
[43]	Bian, B., Mongrain, S., Cagnol, S., Langlois, M.-J., Boulanger, J., Bernatchez, G., Carrier, J.C., Boudreau, F. and Rivard, N. (2015) Cathepsin B Promotes Colorectal Tumorigenesis, Cell Invasion, and Metastasis. Molecular Carcinogenesis. http://dx.doi.org/10.1002/mc.22312
[44]	Fukuno, N., Matsui, H., Kanda, Y., Suzuki, O., Matsumoto, K., Sasaki, K., Kobayashi, T. and Tamura, S. (2011) TGF- Beta-Activated Kinase 1 Mediates Mechanical Stress-Induced IL-6 Expression in Osteoblasts. Biochemical and Biophysical Research Communications, 408, 202-207. http://dx.doi.org/10.1016/j.bbrc.2011.02.127
[45]	Tian, Y., Ye, Y., Gao, W., Chen, H., Song, T., Wang, D.Q., Mao, X.Y. and Ren, C.S. (2011) Aspirin Promotes Apoptosis in a Murine Model of Colorectal Cancer by Mechanisms Involving Downregulation of IL-6-STAT3 Signaling Pathway. International Journal of Colorectal Disease, 26, 13-22. http://dx.doi.org/10.1007/s00384-010-1060-0
[46]	Gulubova, M., Manolova, I., Ananiev, J., Julianov, A., Yovchev, Y. and Peeva, K. (2010) Role of TGF-β1, Its Receptor TGFβRII, and Smad Proteins in the Progression of Colorectal Cancer. International Journal of Colorectal Disease, 25, 591-599. http://dx.doi.org/10.1007/s00384-010-0906-9
[47]	Yamashita, K., Sakuramoto, S., Mieno, H., Nemoto, M., Shi-bata, T., Katada, N., et al. (2015) Preoperative Administration of Polysaccharide Kureha and Reduced Plasma Trans-forming Growth Factor-Beta in Patients with Advanced Gastric Cancer: A Randomized Clinical Trial. Molecular and Clinical Oncology, 3, 471-478.
[48]	David, H. (1988) Rudolf Virchow and Modern Aspects of Tumor Pathology. Pathology—Research and Practice, 183, 356-364. http://dx.doi.org/10.1016/S0344-0338(88)80138-9
[49]	Balkwill, F. and Mantovani, A. (2001) Inflam-mation and Cancer: Back to Virchow? Lancet, 357, 539-545. http://dx.doi.org/10.1016/S0140-6736(00)04046-0
[50]	Hussain, S.P. and Harris, C.C. (2007) Inflammation and Cancer: An Ancient Link with Novel Potentials. International Journal of Cancer, 121, 2373-2380. http://dx.doi.org/10.1002/ijc.23173
[51]	Fernandes, J.V., Cobucci, R.N., Jatoba, C.A., et al. (2015) The Role of the Mediators of Inflammation in Cancer Development. Pathology and Oncology Research, 21, 527-534. http://dx.doi.org/10.1007/s12253-015-9913-z
[52]	Rubin, D.C., Shaker, A. and Levin, M.S. (2012) Chronic Intes-tinal Inflammation: Inflammatory Bowel Disease and Colitis- Associated Colon Cancer. Frontiers in Immunology, 3, 107. http://dx.doi.org/10.3389/fimmu.2012.00107
[53]	Yang, G.Y., Taboada, S. and Liao, J. (2009) Inflammatory Bowel Disease: A Model of Chronic Inflammation-Induced Cancer. Methods in Molecular Biology, 511, 193-233. http://dx.doi.org/10.1007/978-1-59745-447-6_9
[54]	Wilson, A.J., Barham, W., Saskowski, J., et al. (2013) Tracking NF-κB Activity in Tumor Cells during Ovarian Cancer Progression in a Syngeneic Mouse Model. Journal of Ovarian Research, 6, 63. http://dx.doi.org/10.1186/1757-2215-6-63
[55]	Yu, H., Pardoll, D. and Jove, R. (2009) STATs in Cancer In-flammation and Immunity: A Leading Role for STAT3. Nature Reviews Cancer, 9, 798-809. http://dx.doi.org/10.1038/nrc2734
[56]	O’Shea, J.J., Holland, S.M. and Staudt, L.M. (2013) JAKs and STATs in Immunity, Immunodeficiency, and Cancer. The New England Journal of Medicine, 368, 161-170. http://dx.doi.org/10.1056/NEJMra1202117
[57]	Yao, P.L., Morales, J.L., Zhu, B., et al. (2014) Activation of Pe-roxisome Proliferator-Activated Receptor-β/δ (PPAR- β/δ) Inhibits Human Breast Cancer Cell Line Tumorigenicity. Molecular Cancer Therapeutics, 2014, 13, 1008-1017. http://dx.doi.org/10.1158/1535-7163.MCT-13-0836
[58]	Takeda, Y., Yashima, K., Hayashi, A., Sasaki, S., Ka-waguchi, K., Harada, K., Murawaki, Y. and Ito, H. (2012) Expression of AID, P53, and Mlh1 Proteins in Endoscopi-cally Resected Differentiated-Type Early Gastric Cancer. World Journal of Gastrointestinal Oncology, 4, 131-137. http://dx.doi.org/10.4251/wjgo.v4.i6.131
[59]	Lu, H., Ouyang, W. and Huang, C. (2006) Inflammation, a Key Event in Cancer Development. Molecular Cancer Research, 4, 221-233. http://dx.doi.org/10.1158/1541-7786.MCR-05-0261
[60]	Ricciardi, M., Zanotto, M., Malpeli, G., Bassi, G., Per-bellini, O., Chilosi, M., Bifari, F. and Krampera, M. (2015) Epithelial-to-Mesenchymal Transition (EMT) Induced by Inflammatory Priming Elicits Mesenchymal Stromal Cell-Like Immune-Modulatory Properties in Cancer Cells. British Journal of Cancer, 112, 1067-1075. http://dx.doi.org/10.1038/bjc.2015.29
[61]	刘斌, 阳惠湘. 溃疡性结肠炎相关性结直肠癌的危险因素及预防[J]. 国际病理科学与临床杂志, 2012, 32(3): 244- 252.
[62]	Cui, Y. and Li, S. (2014) Hypoxia, Epithelia-Mesenchymal Transition and Cancer. Chinese Journal of Pathology, 43, 203-206.
[63]	Dezso, Z., Oestreicher, J., Weaver, A., Santiago, S., Agoulnik, S., Chow, J., Oda, Y. and Funahashi, Y. (2014) Gene Expression Profiling Reveals Epithelial Mesenchymal Transition (EMT) Genes Can Selectively Differentiate Eribulin Sensitive Breast Cancer Cells. PLoS ONE, 9, e106131. http://dx.doi.org/10.1371/journal.pone.0106131
[64]	Hagerling, C., Casbon, A.J. and Werb, Z. (2015) Balancing the Innate Immune System in Tumor Development. Trends in Cell Biology, 25, 214-220. http://dx.doi.org/10.1016/j.tcb.2014.11.001
[65]	张晶, 钟武, 李松. TNF-α抑制剂的研究进展[J]. 中国药物化学杂志, 2010(4): 310-318.
[66]	杨季云, 张思仲, 郭红. TNF-α通过激活NF-κB信号通路加快肝细胞周期进程[J]. 生物化学与生物物理进展, 2007, 34(6): 604-610.
[67]	向春艳, 何小燕, 李逐波, 刘衍季, 赖翔宇. TNF-α在癌症中的作用研究进展[J]. 生命科学, 2012, 21(3): 250-254.
[68]	王文珊, 傅冷西, 叶君健. TNF-α信号传导通路的研究进展[J]. 福建医科大学学报, 2005, 39(S1): 27-31.
[69]	Valentine, F.T. (1974) Soluble Factors Produced by Lymphocytes. Annals of the New York Academy of Sciences, 221, 317-323. http://dx.doi.org/10.1111/j.1749-6632.1974.tb28232.x
[70]	Wallach, D. (2013) The TNF Cytokine Family: One Track in a Road Paved by Many. Cytokine, 63, 225-229. http://dx.doi.org/10.1016/j.cyto.2013.05.027
[71]	Honchel, R., McDonnell, S., Schaid, D.J. and Thibodeau, S.N. (1996) Tumor Necrosis Factor-Alpha Allelic Frequency and Chromosome 6 Allelic Imbalance in Patients with Colorectal Cancer. Cancer Research, 56, 145-149.
[72]	Whittle, B.J., Varga, C., Berko, A., Horvath, K., Posa, A., Riley, J.P., Lundeen, K.A., Fourie, A.M. and Dunford, P.J. (2008) Attenuation of Inflammation and Cytokine Production in Rat Colitis by a Novel Selective Inhibitor of Leukotriene A4 Hydrolase. British Journal of Pharmacology, 153, 983-991. http://dx.doi.org/10.1038/sj.bjp.0707645
[73]	Chakrabarti, A., Talukdar, D., Pal, A. and Ray, M. (2014) Immunomodulation of Macrophages by Methylglyoxal Conjugated with Chitosan Nanoparticles against Sarcoma-180 Tumor in Mice. Cellular Immunology, 287, 27-35. http://dx.doi.org/10.1016/j.cellimm.2013.11.006
[74]	Chaftari, A.M., Hachem, R., Reitzel, R., Jordan, M., Jiang, Y., Yousif, A., et al. (2015) Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection. PLoS ONE, 10, e130999. http://dx.doi.org/10.1371/journal.pone.0130999
[75]	Do, D.V., Ueda, J., Messerschmidt, D.M., Lorthongpanich, C., Zhou, Y., Feng, B., et al. (2013) A Genetic and Developmental Pathway from STAT3 to the OCT4-NANOG Circuit Is Essential for Maintenance of ICM Lineages in Vivo. Genes & Development, 27, 1378-1390. http://dx.doi.org/10.1101/gad.221176.113
[76]	Qu, Z.X., Sun, F., Zhou, J.J., Li, L.W., Shapiro, S.D. and Xiao, G.T. (2015) Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer. Cancer Research, 75, 3209-3215. http://dx.doi.org/10.1158/0008-5472.CAN-14-3042
[77]	牛秀珑, 王越, 梁国庆. 转化生长因子β的研究进展[J]. 医学综述, 2004, 10(4): 209-210.
[78]	吴学玲, 王先酉. 转化生长因子β的研究进展[J]. 南华大学学报(医学版), 2004, 30(2): 179-180.
[79]	Glansbeek, H.L., van der Kraan, P.M., Lafeber, F.P., Vitters, E.L. and van den Berg, W.B. (1997) Species-Specific Expression of Type II TGF-Beta Receptor Isoforms by Articular Chondrocytes: Effect of Proteoglycan Depletion and Aging. Cytokine, 9, 347-351. http://dx.doi.org/10.1006/cyto.1996.0175
[80]	Kashiwagi, I., Morita, R., Schichita, T., Komai, K., Saeki, K., Matsumoto, M., et al. (2015) Smad2 and Smad3 Inversely Regulate TGF-Beta Autoinduction in Clostridium Butyricum-Activated Dendritic Cells. Immunity, 43, 65-79.
[81]	Goswami, M.T., Reka, A.K., Kurapati, H., Kaza, V., Chen, J., Standiford, T.J. and Keshamouni, V.G. (2015) Regulation of Complement-Dependent Cytotoxicity by TGF-Beta-Induced Epithelial-Mesenchymal Transition. Oncogene. http://dx.doi.org/10.1038/onc.2015.258
[82]	Mendes, F., Antunes, C., Abrantes, A.M., Gon？alves, A.C., No-bre-Gois, I., Sarmento, A.B., Botelho, M.F. and Rosa, M.S. (2015) Lung Cancer: The Immune System and Radiation. British Journal of Biomedical Science, 72, 78-84.
[83]	Guasch, G., Schober, M., Pasolli, H.A., Conn, E.B., Polak, L. and Fuchs, E. (2007) Loss of TGFβ Signaling Destabilizes Homeostasis and Promotes Squamous Cell Carcinomas in Stratified Epithelia. Cancer Cell, 12, 313-327. http://dx.doi.org/10.1016/j.ccr.2007.08.020
[84]	Fearnhead, N.S., Wilding, J.L. and Bodmer, W.F. (2002) Genetics of Colorectal Cancer: Hereditary Aspects and Overview of Colorectal Tumorigenesis. British Medical Bulletin, 64, 27-43. http://dx.doi.org/10.1093/bmb/64.1.27
[85]	Gonzalez-Pons, M. and Cruz-Correa, M. (2015) Colorectal Cancer Biomarkers: Where Are We Now? BioMed Research International, 2015, Article ID: 149014. http://dx.doi.org/10.1155/2015/149014
[86]	Fearon, E.R. and Vogelstein, B. (1990) A Genetic Model for Colo-rectal Tumorigenesis. Cell, 61, 759-767. http://dx.doi.org/10.1016/0092-8674(90)90186-I
[87]	秦淼, 房静远. 炎症小体与肿瘤发生的研究进展[J]. 肿瘤, 2013, 33(6): 556-560.
[88]	Fouad, T.M., Kogawa, T., Reuben, J.M. and Ueno, N.T. (2014) The Role of Inflam-mation in Inflammatory Breast Cancer. Advances in Experimental Medicine and Biology, 816, 53-73. http://dx.doi.org/10.1007/978-3-0348-0837-8_3
[89]	Nittka, S., Gunther, J., Ebisch, C., Erbersdobler, A. and Neumaier, M. (2004) The Human Tumor Suppressor CEACAM1 Modulates Apoptosis and Is Implicated in Early Co-lorectal Tumorigenesis. Oncogene, 23, 9306-9313. http://dx.doi.org/10.1038/sj.onc.1208259
[90]	Bian, B., Mongrain, S., Cagnol, S., Langlois, M.-J., Boulanger, J., Bernatchez, G., Carrier, J.C., Boudreau, F. and Rivard, N. (2015) Cathepsin B Promotes Colorectal Tumorigenesis, Cell Invasion, and Metastasis. Molecular Carcinogenesis. http://dx.doi.org/10.1002/mc.22312
[91]	Fukuno, N., Matsui, H., Kanda, Y., Suzuki, O., Matsumoto, K., Sasaki, K., Kobayashi, T. and Tamura, S. (2011) TGF- Beta-Activated Kinase 1 Mediates Mechanical Stress-Induced IL-6 Expression in Osteoblasts. Biochemical and Biophysical Research Communications, 408, 202-207. http://dx.doi.org/10.1016/j.bbrc.2011.02.127
[92]	Tian, Y., Ye, Y., Gao, W., Chen, H., Song, T., Wang, D.Q., Mao, X.Y. and Ren, C.S. (2011) Aspirin Promotes Apoptosis in a Murine Model of Colorectal Cancer by Mechanisms Involving Downregulation of IL-6-STAT3 Signaling Pathway. International Journal of Colorectal Disease, 26, 13-22. http://dx.doi.org/10.1007/s00384-010-1060-0
[93]	Gulubova, M., Manolova, I., Ananiev, J., Julianov, A., Yovchev, Y. and Peeva, K. (2010) Role of TGF-β1, Its Receptor TGFβRII, and Smad Proteins in the Progression of Colorectal Cancer. International Journal of Colorectal Disease, 25, 591-599. http://dx.doi.org/10.1007/s00384-010-0906-9
[94]	Yamashita, K., Sakuramoto, S., Mieno, H., Nemoto, M., Shi-bata, T., Katada, N., et al. (2015) Preoperative Administration of Polysaccharide Kureha and Reduced Plasma Trans-forming Growth Factor-Beta in Patients with Advanced Gastric Cancer: A Randomized Clinical Trial. Molecular and Clinical Oncology, 3, 471-478.

Full-Text